Lamivudine And Zidovudine Tablet, Film Coated
Product Images NDC 76282-115

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lamivudine And Zidovudine (NDC 76282-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7.5mg-100 (Mm1)

Lamivudine and Zidovudine Tablets, USP containing 150mg Lamivudine and 300mg Zidovudine each. It is Rx only drug and the usual dosage is mentioned on the package insert for Dosage and Administration. The drug should not be used if printed safety seal under the cap is broken or missing. It is manufactured by Ascent Pharmaceuticals, inc. and is stored at 20° to 25°C.*

FDA Label Image

Lamivudine Chemical Structure (Mm2)

FDA Label Image

Zidovudine Chemical Structure (Mm3)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.